| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Axogen, Inc. | CFO | Common Stock | 261K | $3.97M | $15.22 | 06 Jan 2025 | Direct |
| BRAINSTORM CELL THERAPEUTICS INC. | Director | Common Stock | 31.5K | $7.17K | $0.23 | 01 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AXGN | Axogen, Inc. | 06 Jan 2025 | 1 | -$596K | 4 | CFO | 06 Jan 2025, 18:39 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 01 Jan 2025 | 1 | $0 | 4 | Director | 03 Jan 2025, 17:32 |
| AXGN | Axogen, Inc. | 01 Jan 2024 | 1 | $0 | 4 | CFO | 04 Jan 2024, 17:48 |
| AXGN | Axogen, Inc. | 04 Dec 2023 | 0 | $0 | 3 | CFO | 04 Jan 2024, 17:45 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 19 Jun 2023 | 1 | $0 | 4 | Director | 21 Jun 2023, 16:06 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 19 Jun 2023 | 0 | $0 | 3 | Director | 21 Jun 2023, 16:05 |